Cover Image
市場調查報告書

次世代定序市場 2017-2027:各用途、技術、產品、終端用戶及地區的收益預測

The Next Generation Sequencing Market Forecast 2017-2027: Revenue Prospects by Application, Technology, Products, End User and Geography

出版商 Visiongain Ltd 商品編碼 585542
出版日期 內容資訊 英文 248 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
次世代定序市場 2017-2027:各用途、技術、產品、終端用戶及地區的收益預測 The Next Generation Sequencing Market Forecast 2017-2027: Revenue Prospects by Application, Technology, Products, End User and Geography
出版日期: 2017年10月16日 內容資訊: 英文 248 Pages
簡介

本報告提供全球次世代定序的市場調查,市場及技術、產品概要,市場成長的各種影響因素及市場機會分析,各用途、技術、產品、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等彙整。

第1章 報告概要

第2章 次世代定序:市場概要

  • 簡介
    • 市場定義
    • 市場分類
  • 全球市場規模、預測
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 市場趨勢

第3章 市場分析、預測:各用途

  • 簡介
    • 年度成長率比較
  • 市場規模、預測
    • 托曳發現
    • 遺傳學的篩檢
    • 診斷
    • 個人化醫療 (個人化醫療)
    • 農業、動物研究
    • 感染疾病
    • 其他
  • 市場魅力目錄

第4章 市場分析、預測:各技術

  • 簡介
    • 年度成長率比較
  • 市場規模、預測
    • 全基因測序
    • 標的再定序
    • EXOME定序
    • RNA定序
    • 晶片定序
    • De Novo定序
    • 甲基化定序
    • 其他
  • 市場魅力目錄

第5章 市場分析、預測:各產品

  • 簡介
    • 年度成長率比較
  • 市場規模、預測
    • 設備
    • 試劑、消耗品
    • 服務
  • 市場魅力目錄

第6章 市場分析、預測:各終端用戶

  • 簡介
    • 年度成長率比較
  • 市場規模、預測
    • 醫院、醫療保健機關
    • 學術區分
    • 生物科技區分
    • 醫藥品區分
    • 其他
  • 市場魅力目錄

第7章 市場分析、預測:各地區

  • 簡介
    • 年度成長率比較
  • 市場規模、預測
    • 北美
    • 南美
    • 西歐
    • 東歐
    • 亞太地區
    • 中東、非洲
  • 市場魅力目錄

第8章 北美市場分析、預測

第9章 南美市場分析、預測

第10章 西歐市場分析、預測

第11章 東歐市場分析、預測

第12章 亞太地區市場分析、預測

第13章 MEA市場分析、預測

第14章 主要企業

  • 競爭儀表板
  • 企業佔有率分析
  • 企業簡介
    • Illumina, Inc
    • Thermo Fisher Scientific Inc
    • Pacific Biosciences of California, Inc.
    • Qiagen N.V.
    • F. Hoffmann-La Roche AG
    • BGI(Beijing Genomics Institute)
    • PerkinElmer, Inc.
    • Agilent Technologies, Inc.
    • GATC Biotech AG
    • Oxford Nanopore Technologies, Ltd
    • Macrogen, Inc
    • Eurofins Scientific

第15章 總論

第16章 用語

目錄
Product Code: PHA0247

Title:
THE NEXT GENERATION SEQUENCING MARKET FORECAST 2017-2027
Revenue Prospects by Application (Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Others) Technology (Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq), Products, End User (Healthcare Institution, Academics, Biotechnology, Pharmaceutical) and Geography.

Next Generation Sequencing - our new study reveals trends, R&D progress, and predicted revenues

Where is the Next Generation Sequencing market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 248-page report provides 192 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Next Generation Sequencing market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are 4 segmentations of the Next Generation Sequencing market, with forecasts for 7 Applications, 8 Technologies, 3 Product Types and 5 End Users, each forecasted at a global and regional level.

Global Next Generation Sequencing Market by Application

  • Drug Discovery
  • Genetic Screening
  • Diagnostics
  • Personalized Medicine
  • Agriculture and Animal Research
  • Infectious Diseases
  • Others

Global Next Generation Sequencing Market by Technology

  • Whole-Genome Sewuencing
  • Targeted Re-Sequencing
  • Exome Sequencing
  • RNA Seq
  • Chip Seq
  • De Novo Sequencing
  • Methyl Seq
  • Others

Global Next Generation Sequencing Market by Product

  • Instruments
  • Reagents & Consumables
  • Services

Global Next Generation Sequencing Market by End User

  • Hospital & Healthcare Institution
  • Academics
  • Biotechnology
  • Pharmaceutical
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:

  • North America:
    • US
    • Canada
  • Latin America:
    • Brazil
    • Mexico
    • Rest of Latin America
  • Western Europe:
    • Germany
    • The UK
    • Italy
    • France
    • Spain
    • Nordic
    • Benelux
    • Rest of Western Europe
  • Eastern Europe:
    • Russia
    • Poland
    • Rest of Eastern Europe
  • Asia-Pacific:
    • Japan
    • China
    • India
    • Australia & New Zealand
    • ASEAN
    • Rest of Asia-Pacific
  • MEA:
    • GCC Countries
    • South Africa
    • Northern Africa
    • Rest of MEA

The report also includes profiles and for some of the leading companies in the Next Generation Sequencing market, with a focus on this segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, Russia, Germany and China in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth

Overall world revenue for Next Generation Sequencing will surpass $5.6bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Next Generation Sequencing Market report helps you

In summary, our 248-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for 3 segmentations of the Next Generation Sequencing market, with forecasts for 7 Applications, 8 Technologies, 3 Products and 5 End Users Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 6 regional and 21 key national markets - See forecasts for the Next Generation Sequencing market in North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Nordic Countries, Benelux, China, India, Japan, Australia & New Zealand, ASEAN countries, GCC Countries, South Africa and Northern Africa.
  • Stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Next Generation Sequencing market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Next Generation Sequencing market and leading companies. You will find data, trends and predictions.

Get our report today The Next Generation Sequencing Market Forecast 2017-2027: Revenue Prospects by Application (Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture And Animal Research, Infectious Diseases, Others) Technology (Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Others), Products (Instruments, Reagents & Consumables, Services), End User (Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others) and Geography.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Introduction
  • 1.2. Why You Should Read This Report
  • 1.3. Key Questions Answered by This Analytical Report
  • 1.4. Who is This Report For?
  • 1.5. Methodology
  • 1.6. Frequently Asked Questions(FAQ)
  • 1.7. Associated Visiongain Reports
  • 1.8. About Visiongain

2. Next-Generation Sequencing Market Overview

  • 2.1. Introduction
    • 2.1.1. Market Definition
    • 2.1.2. Market Taxonomy
  • 2.2. Global Next-Generation Sequencing Market Size and Forecast
  • 2.3. Market Dynamics
    • 2.3.1. Global NGS Market: Drivers
      • 2.3.1.1. Technological Advancements in Sequencing Platforms
      • 2.3.1.2. Increasing Applications of NGS
      • 2.3.1.3. Minimizing Growing Number of Partnerships and Collaborations
      • 2.3.1.4. Increasing Adoption of NGS Technologies among Research Laboratories and Academic Institutes
      • 2.3.1.5. Conferences and Workshops Increasing Awareness on NGS Products and Services
    • 2.3.2. Global Next-Generation Sequencing Market: Restraints
      • 2.3.2.1. Dearth of Skilled Professionals
      • 2.3.2.2. Difficulties in Storage of Sequencing Data
    • 2.3.3. Global Next-Generation Sequencing Market: Opportunity
      • 2.3.3.1. Government Initiatives in Population Sequencing
      • 2.3.3.2. Application of NGS in Precision Medicine & Biomarker Discovery
      • 2.3.3.3. Emerging Markets Offer Significant Growth Opportunities
      • 2.3.3.4. Cloud Computing, A Prospective Service
    • 2.3.4. Global Next-Generation Sequencing Market: Trends
      • 2.3.4.1. Integration of Next-Generation Sequencing with Cloud-Based Technology
      • 2.3.4.2. Focus on Cancer Research
      • 2.3.4.3. Mergers and Acquisitions
      • 2.3.4.4. Entry of New Market Players

3. Global Next-Generation Sequencing Market Analysis and Forecast, By Application

  • 3.1. Introduction
    • 3.1.1. Global NGS Market, Annual Growth Rate Comparison, By Application
  • 3.2. Global Next-Generation Sequencing Market Size and Forecast, By Application
    • 3.2.1. Drug Discovery Segment
    • 3.2.2. Genetic Screening Segment
    • 3.2.3. Diagnostics
    • 3.2.4. Personalized Medicine
    • 3.2.5. Agriculture & Animal Research
    • 3.2.6. Infectious Diseases
    • 3.2.7. Others
  • 3.3. Global Next-Generation Sequencing Attractiveness Index, By Application

4. Global Next-Generation Sequencing Market Analysis and Forecast, By Technology

  • 4.1. Introduction
    • 4.1.1. Global Next-Generation Sequencing Market, Annual Growth Rate Comparison, By Technology
  • 4.2. Global Next-Generation Sequencing Market Size and Forecast, By Technology
    • 4.2.1. Whole-Genome Sequencing Segment
    • 4.2.2. Targeted Re-Sequencing Segment
    • 4.2.3. Exome Sequencing Segment
    • 4.2.4. RNA Seq Segment
    • 4.2.5. Chip Seq Segment
    • 4.2.6. De Novo Sequencing Segment
    • 4.2.7. Methyl Seq Segment
    • 4.2.8. Others Segment
  • 4.3. Global NGS Market Attractiveness Index, By Technology

5. Global NGS Market Analysis and Forecast, By Products

  • 5.1. Introduction
    • 5.1.1. Global NGS Market, Annual Growth Rate Comparison, By Products
  • 5.2. Global NGS Market Size and Forecast, By Products
    • 5.2.1. Instruments Segment
    • 5.2.2. Reagents & Consumables Segment
    • 5.2.3. Services Segment
  • 5.3. Global NGS Market Attractiveness Index, By Products

6. Global NGS Market Analysis and Forecast, By End User

  • 6.1. Introduction
    • 6.1.1. Global NGS Market, Annual Growth Rate Comparison, By End User
  • 6.2. Global NGS Market Size and Forecast, By End User
    • 6.2.1. Hospital & Healthcare Institution Segment
    • 6.2.2. Academics Segment
    • 6.2.3. Biotechnology Segment
    • 6.2.4. Pharmaceutical Segment
    • 6.2.5. Others Segment
  • 6.3. Global NGS Market Attractiveness Index, By End User

7. Global NGS Market Analysis and Forecast, By Region

  • 7.1. Introduction
    • 7.1.1. Global NGS Market, Annual Growth Rate Comparison, By Region
  • 7.2. Global NGS Market Size and Forecast, By Region
    • 7.2.1. North America
    • 7.2.2. Latin America
    • 7.2.3. Western Europe
    • 7.2.4. Eastern Europe
    • 7.2.5. Asia Pacific
    • 7.2.6. MEA
  • 7.3. Global NGS Market Attractiveness Index, By Region

8. North America NGS Market Analysis and Forecast, 2016-2027

  • 8.1. Introduction
    • 8.1.1. North America NGS Market
    • 8.1.2. North America NGS Market, Annual Growth Rate Comparison, By Country
  • 8.2. North America NGS Market Size and Forecast, By Country
    • 8.2.1. The U.S. NGS Market
    • 8.2.2. Canada NGS Market
  • 8.3. North America NGS Market Size and Forecast, By Application
  • 8.4. North America NGS Market Size and Forecast, By Technology
  • 8.5. North America NGS Market Size and Forecast, By Products
  • 8.6. North America NGS Market Size and Forecast, By End User
  • 8.7. North America NGS Market Attractiveness Index
    • 8.7.1. North America NGS Market Attractiveness Index, By Country
    • 8.7.2. North America NGS Market Attractiveness Index, By Application
    • 8.7.3. North America NGS Market Attractiveness Index, By Technology
    • 8.7.4. North America NGS Market Attractiveness Index, By Products
    • 8.7.5. North America NGS Market Attractiveness Index, By End User

9. Latin America NGS Market Analysis and Forecast, 2016-2027

  • 9.1. Introduction
    • 9.1.1. Latin America NGS Market
    • 9.1.2. Latin America NGS Market, Annual Growth Rate Comparison, By Country
  • 9.2. Latin America NGS Market Size and Forecast, By Country
    • 9.2.1. Brazil NGS Market
    • 9.2.2. Mexico NGS Market
    • 9.2.3. Rest of Latin America NGS Market
  • 9.3. Latin America NGS Market Size and Forecast, By Application
  • 9.4. Latin America NGS Market Size and Forecast, By Technology
  • 9.5. Latin America NGS Market Size and Forecast, By Products
  • 9.6. Latin America NGS Market Size and Forecast, By End User
  • 9.7. Latin America NGS Market Attractiveness Index
    • 9.7.1. Latin America NGS Market Attractiveness Index, By Country
    • 9.7.2. Latin America NGS Market Attractiveness Index, By Application
    • 9.7.3. Latin America NGS Market Attractiveness Index, By Technology
    • 9.7.4. Latin America NGS Market Attractiveness Index, By Products
    • 9.7.5. Latin America NGS Market Attractiveness Index, By End User

10. Western Europe NGS Market Analysis and Forecast, 2017-2027

  • 10.1. Introduction
    • 10.1.1. Western Europe NGS Market
    • 10.1.2. Western Europe NGS Market, Annual Growth Rate Comparison, By Country
  • 10.2. Western Europe NGS Market Size and Forecast, By Country
    • 10.2.1. U.K. NGS Market
    • 10.2.2. France NGS Market
    • 10.2.3. Germany NGS Market
    • 10.2.4. Italy NGS Market
    • 10.2.5. Spain NGS Market
    • 10.2.6. Nordic NGS Market
    • 10.2.7. Benelux NGS Market
    • 10.2.8. Rest of Western Europe NGS Market
  • 10.3. Western Europe NGS Market Size and Forecast, By Application
  • 10.4. Western Europe NGS Market Size and Forecast, By Technology
  • 10.5. Western Europe NGS Market Size and Forecast, By Products
  • 10.6. Western Europe NGS Market Size and Forecast, By End User
  • 10.7. Western Europe NGS Market Attractiveness Index
    • 10.7.1. Western Europe NGS Market Attractiveness Index, By Country
    • 10.7.2. Western Europe NGS Market Attractiveness Index, By Application
    • 10.7.3. Western Europe NGS Market Attractiveness Index, By Technology
    • 10.7.4. Western Europe NGS Market Attractiveness Index, By Products
    • 10.7.5. Western Europe NGS Market Attractiveness Index, By End User

11. Eastern Europe NGS Market Analysis and Forecast, 2017-2027

  • 11.1. Introduction
    • 11.1.1. Eastern Europe NGS Market
    • 11.1.2. Eastern Europe NGS Market, Annual Growth Rate Comparison, By Country
  • 11.2. Eastern Europe NGS Market Size and Forecast, By Country
    • 11.2.1. Russia NGS Market
    • 11.2.2. Poland NGS Market
    • 11.2.3. Rest of Eastern Europe NGS Market
  • 11.3. Eastern Europe NGS Market Size and Forecast, By Application
  • 11.4. Eastern Europe NGS Market Size and Forecast, By Technology
  • 11.5. Eastern Europe NGS Market Size and Forecast, By Products
  • 11.6. Eastern Europe NGS Market Size and Forecast, By End User
  • 11.7. Eastern Europe NGS Market Attractiveness Index
    • 11.7.1. Eastern Europe NGS Market Attractiveness Index, By Country
    • 11.7.2. Eastern Europe NGS Market Attractiveness Index, By Application
    • 11.7.3. Eastern Europe NGS Market Attractiveness Index, By Technology
    • 11.7.4. Eastern Europe NGS Market Attractiveness Index, By Products
    • 11.7.5. Eastern Europe NGS Market Attractiveness Index, By End User

12. Asia Pacific NGS Market Analysis and Forecast, 2017-2027

  • 12.1. Introduction
    • 12.1.1. Asia Pacific NGS Market
    • 12.1.2. Asia Pacific NGS Market, Annual Growth Rate Comparison, By Country
  • 12.2. Asia Pacific NGS Market Size and Forecast, By Country
    • 12.2.1. China NGS Market
    • 12.2.2. India NGS Market
    • 12.2.3. Australia and New Zealand NGS Market
    • 12.2.4. ASEAN NGS Market
    • 12.2.5. Japan NGS Market
    • 12.2.6. Rest of Asia Pacific NGS Market
  • 12.3. Asia Pacific NGS Market Size and Forecast, By Application
  • 12.4. Asia Pacific NGS Market Size and Forecast, By Technology
  • 12.5. Asia Pacific NGS Market Size and Forecast, By Products
  • 12.6. Asia Pacific NGS Market Size and Forecast, By End User
  • 12.7. Asia Pacific NGS Market Attractiveness Index
    • 12.7.1. Asia Pacific NGS Market Attractiveness Index, By Country
    • 12.7.2. Asia Pacific NGS Market Attractiveness Index, By Application
    • 12.7.3. Asia Pacific NGS Market Attractiveness Index, By Technology
    • 12.7.4. Asia Pacific NGS Market Attractiveness Index, By Products
    • 12.7.5. Asia Pacific NGS Market Attractiveness Index, By End User

13. MEA NGS Market Analysis and Forecast, 2017-2027

  • 13.1. Introduction
    • 13.1.1. MEA NGS Market
    • 13.1.2. MEA NGS Market, Annual Growth Rate Comparison, By Country
  • 13.2. MEA NGS Market Size and Forecast, By Country
    • 13.2.1. GCC Countries NGS Market
    • 13.2.2. South Africa NGS Market
    • 13.2.3. North Africa NGS Market
    • 13.2.4. Rest of MEA NGS Market
  • 13.3. MEA NGS Market Size and Forecast, By Application
  • 13.4. MEA NGS Market Size and Forecast, By Technology
  • 13.5. MEA NGS Market Size and Forecast, By Products
  • 13.6. MEA NGS Market Size and Forecast, By End User
  • 13.7. MEA NGS Market Attractiveness Index
    • 13.7.1. MEA NGS Market Attractiveness Index, By Country
    • 13.7.2. MEA NGS Market Attractiveness Index, By Application
    • 13.7.3. MEA NGS Market Attractiveness Index, By Technology
    • 13.7.4. MEA NGS Market Attractiveness Index, By Products
    • 13.7.5. MEA NGS Market Attractiveness Index, By End User

14. Leading Companies in the Next-Generation Sequencing Market

  • 14.1. Competition Dashboard
  • 14.2. Company Share Analysis
  • 14.3. Company Profiles
    • 14.3.1. Illumina, Inc
      • 14.3.1.1. Basic Information
      • 14.3.1.2. Company Overview
      • 14.3.1.3. Product Offerings
      • 14.3.1.4. Financial Statements
      • 14.3.1.5. Company Strategy
      • 14.3.1.6. Key Developments
    • 14.3.2. Thermo Fisher Scientific Inc
      • 14.3.2.1. Basic Information
      • 14.3.2.2. Company Overview
      • 14.3.2.3. Product Offering
      • 14.3.2.4. Financial Statements
      • 14.3.2.5. Company Strategy
      • 14.3.2.6. Key Developments
    • 14.3.3. Pacific Biosciences of California, Inc.
      • 14.3.3.1. Basic Information
      • 14.3.3.2. Company Overview
      • 14.3.3.3. Product Offering
      • 14.3.3.4. Financial Statements
      • 14.3.3.5. Company Strategy
      • 14.3.3.6. Key Developments
    • 14.3.4. Qiagen N.V.
      • 14.3.4.1. Basic Information
      • 14.3.4.2. Company Overview
      • 14.3.4.3. Product Offering
      • 14.3.4.4. Financial Statements
      • 14.3.4.5. Company Strategy
      • 14.3.4.6. Key Developments
    • 14.3.5. F. Hoffmann-La Roche AG
      • 14.3.5.1. Basic Information
      • 14.3.5.2. Company Overview
      • 14.3.5.3. Product Offering
      • 14.3.5.4. Financial Statements
      • 14.3.5.5. Company Strategy
      • 14.3.5.6. Key Developments
    • 14.3.6. BGI(Beijing Genomics Institute)
      • 14.3.6.1. Basic Information
      • 14.3.6.2. Company Overview
      • 14.3.6.3. Product Offering
      • 14.3.6.4. Company Strategy
      • 14.3.6.5. Key Developments
    • 14.3.7. PerkinElmer, Inc.
      • 14.3.7.1. Basic Information
      • 14.3.7.2. Company Overview
      • 14.3.7.3. Product Offering
      • 14.3.7.4. Financial Statements
      • 14.3.7.5. Company Strategy
      • 14.3.7.6. Key Developments
    • 14.3.8. Agilent Technologies, Inc.
      • 14.3.8.1. Basic Information
      • 14.3.8.2. Company Overview
      • 14.3.8.3. Product Offering
      • 14.3.8.4. Financial Statements
      • 14.3.8.5. Company Strategy
      • 14.3.8.6. Key Developments
    • 14.3.9. GATC Biotech AG
      • 14.3.9.1. Basic Information
      • 14.3.9.2. Company Overview
      • 14.3.9.3. Product Offering
    • 14.3.10. Oxford Nanopore Technologies, Ltd
      • 14.3.10.1. Basic Information
      • 14.3.10.2. Company Overview
      • 14.3.10.3. Product Offering
      • 14.3.10.4. Company Strategy
      • 14.3.10.5. Key Developments
    • 14.3.11. Macrogen, Inc
      • 14.3.11.1. Basic Information
      • 14.3.11.2. Company Overview
      • 14.3.11.3. Product Offering
      • 14.3.11.4. Company Strategy
      • 14.3.11.5. Key Developments
    • 14.3.12. Eurofins Scientific
      • 14.3.12.1. Basic Information
      • 14.3.12.2. Company Overview
      • 14.3.12.3. Product Offering
      • 14.3.12.4. Financial Statements
      • 14.3.12.5. Strategy
      • 14.3.12.6. Key Developments

15. Conclusion

16. Glossary

  • Visiongain Report Sales Order Form
  • Associated Visiongain Reports
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 2.1: Global Next-Generation Sequencing Market Value Forecast(US$m) and AGR(%), 2015-2027
  • Figure 3.1: Global Next-Generation Sequencing Market AGR(%) Comparison, By Application Segment, 2015-2027
  • Figure 3.2: Global Next-Generation Sequencing Market AGR(%) Comparison, By Application Segment, 2015-2027
  • Figure 3.4: Global Drug Discovery Next-Generation Sequencing Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 3.5: Global Genetic Screening Next-Generation Sequencing Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 3.6: Global Diagnostics Next-Generation Sequencing Market Value Forecast(US$m) and AGR(%), By Segment, 2014-2027
  • Figure 3.7: Global Personalized Medicine Next-Generation Sequencing Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 3.8: Global Agriculture & Animal Research Next-Generation Sequencing Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 3.9: Global Infectious Diseases Next-Generation Sequencing Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 3.10: Global Other Next-Generation Sequencing Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 3.11: Global NGS Market Attractiveness Index, By Application, 2017-2027
  • Figure 4.1: Global Next-Generation Sequencing Market AGR(%) Comparison, By Technology Segment, 2015-2027
  • Figure 4.2: Global Next-Generation Sequencing Market Value Forecast(US$m) and AGR(%), By Whole-Genome Sequencing Segment, 2014-2027
  • Figure 4.3: Global Next-Generation Sequencing Market Value Forecast(US$m) and AGR(%), By Targeted Re-Sequencing Segment, 2014-2027
  • Figure 4.4: Global NGS Market Value Forecast(US$m) and AGR(%), By Exome Sequencing Segment, 2014-2027
  • Figure 4.5: Global NGS Market Value Forecast(US$m) and AGR(%), By RNA Seq Segment, 2014-2027
  • Figure 4.6: Global NGS Market Value Forecast(US$m) and AGR(%), By Chip Seq Segment, 2014-2027
  • Figure 4.7: Global NGS Market Value Forecast(US$m) and AGR(%), By De Novo Sequencing Segment, 2014-2027
  • Figure 4.8: Global NGS Market Value Forecast(US$m) and AGR(%), By Methyl Seq Segment, 2014-2027
  • Figure 4.9: Global NGS Market Value Forecast(US$m) and AGR(%), By Others Segment, 2014-2027
  • Figure 4.14: Global NGS Market Attractiveness Index, By Technology, 2017-2027
  • Figure 5.1: Global NGS Market AGR(%) Comparison, By Products Segment, 2015-2027
  • Figure 5.2: Global NGS Market Value Forecast(US$m) and AGR(%), By Instruments Segment, 2014-2027
  • Figure 5.3: Global NGS Market Value Forecast(US$m) and AGR(%), By Reagents & Consumables Segment, 2014-2027
  • Figure 5.3: Global NGS Market Value Forecast(US$m) and AGR(%), By Services Segment, 2014-2027
  • Figure 5.4: Global NGS Market Attractiveness Index, By Products, 2017-2027
  • Figure 6.1: Global NGS Market AGR(%) Comparison, By End User Segment, 2015-2027
  • Figure 6.2: Global NGS Market Value Forecast(US$m) and AGR(%), By Hospital & Healthcare Institution Segment, 2014-2027
  • Figure 6.3: Global NGS Market Value Forecast(US$m) and AGR(%), By Academics Segment, 2014-2027
  • Figure 6.4: Global NGS Market Value Forecast(US$m) and AGR(%), By Biotechnology Segment, 2014-2027
  • Figure 6.5: Global NGS Market Value Forecast(US$m) and AGR(%), By Pharmaceutical Segment, 2014-2027
  • Figure 6.5: Global NGS Market Value Forecast(US$m) and AGR(%), By Others Segment, 2014-2027
  • Figure 6.6: Global NGS Market Attractiveness Index, By End User, 2017-2027
  • Figure 7.1: Global NGS Market AGR(%) Comparison, By Region, 2015-2027
  • Figure 7.2: North American NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 7.3: Latin American NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 7.4: Western European NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 7.5: Eastern European NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 7.6: Asia Pacific NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 7.7: MEA NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 7.8: Global NGS Market Attractiveness Index, By Region, 2017-2027
  • Figure 8.1: North American NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 8.2: North American NGS Market AGR(%) Comparison, By Country, 2015-2027
  • Figure 8.3: US NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 8.4: Canadian NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 8.5: North American NGS Market Attractiveness Index, By Country, 2017-2027
  • Figure 8.6: North American NGS Market Attractiveness Index, By Application, 2017-2027
  • Figure 8.7: North American NGS Market Attractiveness Index, By Technology, 2017-2027
  • Figure 8.8: North American NGS Market Attractiveness Index, By Products, 2017-2027
  • Figure 8.9: North American NGS Market Attractiveness Index, By End User, 2017-2027
  • Figure 9.1: Latin America NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 9.2: Latin America NGS Market AGR(%) Comparison, By Country, 2015-2027
  • Figure 9.3: Brazilian NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 9.4: Mexican NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 9.5: Latin America NGS Market Value Forecast(US$m) and AGR(%), By Rest of Latin America, 2014-2027
  • Figure 9.6: Latin America NGS Market Attractiveness Index, By Country, 2017-2027
  • Figure 9.7: Latin America NGS Market Attractiveness Index, By Application, 2017-2027
  • Figure 9.8: Latin America NGS Market Attractiveness Index, By Technology, 2017-2027
  • Figure 9.9: Latin America NGS Market Attractiveness Index, By Products, 2017-2027
  • Figure 9.10: Latin America NGS Market Attractiveness Index, By End User, 2017-2027
  • Figure 10.1: Western Europe NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 10.2: Western Europe NGS Market AGR(%) Comparison, By Country, 2015-2027
  • Figure 10.3: UK NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 10.4: French NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 10.5: German NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 10.6: Italian NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 10.7: Spanish NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 10.8: Nordic NGS Market Value(US$m) Forecast and AGR(%),2014-2027
  • Figure 10.9: Benelux NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 10.10: Rest of Western Europe NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 10.11: Western Europe NGS Market Attractiveness Index, By Country, 2017-2027
  • Figure 10.12: Western Europe NGS Market Attractiveness Index, By Application, 2017-2027
  • Figure 10.13: Western Europe NGS Market Attractiveness Index, By Technology, 2017-2027
  • Figure 10.14: Western Europe NGS Market Attractiveness Index, By Products, 2017-2027
  • Figure 10.15: Western Europe NGS Market Attractiveness Index, By End User, 2017-2027
  • Figure 11.1: Eastern Europe NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 11.2: Eastern Europe NGS Market AGR(%) Comparison, By Country, 2015-2027
  • Figure 11.3: Russian NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 11.4: Polish NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 11.5: Rest of Eastern Europe NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 11.6: Eastern Europe NGS Market Attractiveness Index, By Country, 2017-2027
  • Figure 11.7: Eastern Europe NGS Market Attractiveness Index, By Application, 2017-2027
  • Figure 11.8: Eastern Europe NGS Market Attractiveness Index, By Technology, 2017-2027
  • Figure 11.9: Eastern Europe NGS Market Attractiveness Index, By Products, 2017-2027
  • Figure 11.10: Eastern Europe NGS Market Attractiveness Index, By End User, 2017-2027
  • Figure 12.1: Asia Pacific NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 12.2: Asia Pacific NGS Market AGR(%) Comparison, By Country, 2015-2027
  • Figure 12.3: Chinese NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 12.4: Indian NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 12.5: Australia and New Zealand NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 12.6: ASEAN NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 12.7: Japanese NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 12.8: Rest of Asia Pacific NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 12.9: Asia Pacific NGS Market Attractiveness Index, By Country, 2017-2027
  • Figure 12.10: Asia Pacific NGS Market Attractiveness Index, By Application, 2017-2027
  • Figure 12.11: Asia Pacific NGS Market Attractiveness Index, By Technology, 2017-2027
  • Figure 12.12: Asia Pacific NGS Market Attractiveness Index, By Products, 2017-2027
  • Figure 12.13: Asia Pacific NGS Market Attractiveness Index, By End User, 2017-2027
  • Figure 13.1: MEA NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 13.2: MEA NGS Market AGR(%) Comparison, By Country, 2015-2027
  • Figure 13.3: MEA NGS Market Value Forecast(US$m) and AGR(%), By GCC Countries, 2014-2027
  • Figure 13.4: South African NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 13.5: North African NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 13.6: Rest of MEA NGS Market Value Forecast(US$m) and AGR(%), 2014-2027
  • Figure 13.7: MEA NGS Market Attractiveness Index, By Country, 2017-2027
  • Figure 13.8: MEA NGS Market Attractiveness Index, By Application, 2017-2027
  • Figure 13.9: MEA NGS Market Attractiveness Index, By Technology, 2017-2027
  • Figure 13.10: MEA NGS Market Attractiveness Index, By Products, 2017-2027
  • Figure 13.11: MEA NGS Market Attractiveness Index, By End User, 2017-2027
  • Figure 14.1: Leading NGS Companies, By Market Share(%), 2016
  • Figure 14.2: Illumina, Inc Geographical Percentage Split(2016)
  • Figure 14.3: Thermo Fisher Scientific Inc Segment Percentage Split
  • Figure 14.4: Thermo Fisher Scientific IncGeographical Percentage Split(2016)
  • Figure 14.5: Qiagen N.V. Segment Percentage Split
  • Figure 14.6: Qiagen N.V, Inc.Geographical Percentage Split
  • Figure 14.7: F. Hoffmann-La Roche AG Segment Percentage Split
  • Figure 14.8: F. Hoffmann-La Roche AG Segment Geographical Percentage Split
  • Figure 14.9: Agilent Technologies, Inc, Segment Percentage Split
  • Figure 15.1: NGS Market Drivers and Restraints

List of Tables

  • Table 2.1: Next-Generation Sequencing(NGS) Market Segmentation
  • Table 3.1: Global Next-Generation Sequencing Market Value(US$m) Forecast, By Technology, 2016-2027
  • Table 3.2: Global Next-Generation Sequencing Market Forecast,($m, AGR%) 2016-2027
  • Table 4.1: Global Next-Generation Sequencing Market Forecast, By Technology($m, AGR%) 2016-2027
  • Table 4.1: Global Next-Generation Sequencing Market Forecast, By Technology($m, AGR%) 2016-2027(continued)
  • Table 5.1: Global NGS Market Value(US$m) Forecast, By Product, 2016-2027
  • Table 6.1: Global NGS Market Forecast, By End User($m, AGR%) 2016-2027
  • Table 7.1: Global NGS Market Forecast, By Region($m, AGR%, CAGR%) 2016-2027
  • Table 8.1: North American NGS Market Forecast, By Application($m, AGR%) 2016-2027
  • Table 8.2: North American NGS Market Forecast, By Technology($m, AGR%) 2016-2027
  • Table 8.2: North American NGS Market Forecast, By Technology($m, AGR%) 2016-2027(continued)
  • Table 8.3: North American NGS Market Forecast, By Products($m, AGR%) 2016-2027
  • Table 8.4: North American NGS Market Forecast, By End User($m, AGR%) 2016-2027
  • Table 9.1: Latin America NGS Market Forecast,($m, AGR%) 2016-2027
  • Table 9.2: Latin America NGS Market Forecast, By Application($m, AGR%) 2016-2027
  • Table 9.3: Latin America NGS Market Forecast, By Technology($m, AGR%) 2016-2027
  • Table 9.3: Latin America NGS Market Forecast, By Technology($m, AGR%) 2016-2027(continued)
  • Table 9.4: Latin America NGS Market Forecast, By Products($m, AGR%) 2016-2027
  • Table 9.5: Latin America NGS Market Forecast, By End User($m, AGR%) 2016-2027
  • Table 10.1: Western Europe NGS Market Forecast,($m, AGR%) 2016-2027
  • Table 10.2: Western Europe NGS Market Forecast, By Application($m, AGR%) 2016-2027
  • Table 10.3: Western Europe NGS Market Forecast, By Technology($m, AGR%) 2016-2027
  • Table 10.3: Western Europe NGS Market Forecast, By Technology($m, AGR%) 2016-2027(continued)
  • Table 10.4: Western Europe NGS Market Forecast, By Products($m, AGR%) 2016-2027
  • Table 10.5: Western Europe NGS Market Forecast, By End User($m, AGR%) 2016-2027
  • Table 11.1: Eastern Europe NGS Market Forecast,($m, AGR%) 2016-2027
  • Table 11.2: Eastern Europe NGS Market Forecast, By Application($m, AGR%) 2016-2027
  • Table 11.3: Eastern Europe NGS Market Forecast, By Technology($m, AGR%) 2016-2027
  • Table 11.3: Eastern Europe NGS Market Forecast, By Technology($m, AGR%) 2016-2027(continued)
  • Table 11.4: Eastern Europe NGS Market Forecast, By Products($m, AGR%) 2016-2027
  • Table 11.5: Eastern Europe NGS Market Forecast, By End User($m, AGR%) 2016-2027
  • Table 12.1: Asia Pacific NGS Market Forecast,($m, AGR%) 2016-2027
  • Table 12.2: Asia Pacific NGS Market Forecast, By Application($m, AGR%) 2016-2027
  • Table 12.3: Asia Pacific NGS Market Forecast, By Technology($m, AGR%) 2016-2027
  • Table 12.3: Asia Pacific NGS Market Forecast, By Technology($m, AGR%) 2016-2027(continued)
  • Table 12.4: Asia Pacific NGS Market Forecast, By Products($m, AGR%) 2016-2027
  • Table 12.5: Asia Pacific NGS Market Forecast, By End User($m, AGR%) 2016-2027
  • Table 13.1: MEA NGS Market Forecast,($m, AGR%) 2016-2027
  • Table 13.2: MEA NGS Market Forecast, By Application($m, AGR%) 2016-2027
  • Table 13.3: MEA NGS Market Forecast, By Technology($m, AGR%) 2016-2027
  • Table 13.4: MEA NGS Market Forecast, By Products($m, AGR%) 2016-2027
  • Table 13.5: MEA NGS Market Forecast, By End User($m, AGR%) 2016-2027
  • Table 14.1: Next-Generation Sequencing Market Competitive Overview
  • Table 14.1: Next-Generation Sequencing Market Competitive Overview(cont.)
  • Table 14.2: Illumina, Inc. Overview, 2016
  • Table 14.3: Illumina, Inc. Financial Overview, 2014-2016
  • Table 14.4: Illumina, IncRecent Developments
  • Table 14.5: Thermo Fisher Scientific Inc Overview, 2016
  • Table 14.7: Thermo Fisher Scientific Inc Developments
  • Table 14.8: Pacific Biosciences of California, Inc., Overview, 2016
  • Table 14.9: Pacific Biosciences of California, Inc, Financial Overview, 2014-2016
  • Table 14.10: Pacific Biosciences of California, Inc Recent Developments
  • Table 14.13: Qiagen N.V. Recent Developments
  • Table 14.14: F. Hoffmann-La Roche AG, Overview, 2016
  • Table 14.15: F. Hoffmann-La Roche AG, Financial Overview, 2014-2016
  • Table 14.16: F. Hoffmann-La Roche AG Recent Developments
  • Table 14.17: BGI, Overview, 2016
  • Table 14.18: Beijing Genomics Institute, Recent Developments
  • Table 14.19: PerkinElmer, Inc, Overview, 2016
  • Table 14.20: PerkinElmer, Inc.Financial Overview, 2014-2016
  • Table 14.21: PerkinElmer, Inc. Recent Developments
  • Table 14.22: Agilent Technologies, Inc, Overview, 2016
  • Table 14.23: Agilent Technologies, Inc Financial Overview, 2014-2016
  • Table 14.24: Agilent Technologies, Inc. Recent Developments
  • Table 14.25: GATC Biotech AG,Overview, 2016
  • Table 14.26: Oxford Nanopore Technologies, Ltd ,Overview, 2016
  • Table 14.27: Oxford Nanopore Technologies, Ltd. Recent Developments
  • Table 14.28: Macrogen, Inc ,Overview, 2016
  • Table 14.29: Macrogen, Inc. Recent Developments
  • Table 14.30: Eurofins Scientific ,Overview, 2016
  • Table 14.31: Eurofins Scientific Financial Overview, 2014-2016
  • Table 14.32: Eurofins Scientific Recent Developments

Companies Listed

  • 10x Genomics, Inc.
  • 23andMe, Inc.
  • Abbott Laboratories
  • ACT Genomics Co., Ltd.
  • Adaptive Biotechnologies Corporation
  • Admera Health
  • Advanced Biological Laboratories(ABL), S.A.
  • Agilent Technologies Inc.
  • AltheaDx, Inc.
  • Ambry Genetics Corp.
  • Aperiomics, Inc.
  • Asuragen, Inc.
  • Athena Diagnostics, Inc.(A Quest Diagnostics Business)
  • Base4 Innovation Ltd
  • Beckman Coulter, Inc.(Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company(BD)
  • BGI
  • Bina Technologies, Inc.(Part of Roche Sequencing)
  • BioDiscovery, Inc.
  • Biomatters Ltd.
  • bioMérieux S.A.
  • bioTheranostics, Inc.
  • Cancer Genetics, Inc.
  • CareDx, Inc.
  • Caris Life Sciences
  • CLC bio(A QIAGEN Company)
  • Color Genomics, Inc.
  • Complete Genomics(A BGI Company)
  • Courtagen Life Sciences, Inc.
  • Cynvenio Biosystems, Inc.
  • DNA Electronics Ltd.
  • Eurofins Genomics
  • Exosome Diagnostics, Inc.
  • Foundation Medicine, Inc.
  • GATC Biotech AG
  • GenapSys, Inc.
  • GenDx
  • GENEWIZ Inc.
  • Genia Technologies, Inc.(Part of Roche Sequencing)
  • Genomic Health, Inc.
  • Genoptix(A Novartis Company)
  • GnuBIO, Inc.(A Bio-Rad Company)
  • GRAIL
  • Guardant Health, Inc.
  • Helix
  • HTG Molecular Diagnostics
  • Human Longevity, Inc.
  • Illumina, Inc.
  • Inivata Ltd.
  • Invitae Corporation
  • Invivoscribe Technologies, Inc.
  • Laboratory Corporation of America(LabCorp)
  • Lasergen, Inc.
  • MolecularMD Corporation
  • Myriad Genetics, Inc.
  • NANTOMICS(Member of the NantWorks ecosystem of companies)Culver city, CA
  • Natera, Inc.
  • NeoGenomics, Inc./NeoGenomics Laboratories
  • N-of-One, Inc.
  • OncoDNA S.A.
  • Oncospire Genomics
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • Pathway Genomics Corporation
  • Personal Genome Diagnostics, Inc.
  • Personalis, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics
  • RainDance Technologies, Inc.
  • Roche
  • Siemens Healthcare Diagnostics
  • Stratos Genomics Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc..

List of Organizations:

  • European Medicines Agency
  • Food Drug and Administration
  • Ministry of Health, Labor and Welfare
  • World Health Organization
Back to Top